Concepedia

Kie Yoshida‐Tanaka

KY

13

Publications

624

Citations

11

H-Index

2013

Active since

Affiliations

Tokyo Medical and Dental University(Current)

The University of Tokyo

Japan Science and Technology Agency

Tokyo University of Science

Ionis Pharmaceuticals (United States)

Kie Yoshida‐Tanaka is an author at Tokyo Medical and Dental University specializing in cell biology, medicine, and immunology.

Top concepts

Publications per year

2013–2022

13

Publications

13

Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood–brain barrier and knock down genes in the rodent CNS

Tetsuya Nagata, Chrissa A. Dwyer, Kie Yoshida‐Tanaka et al. · Nature Biotechnology · 2021 · 136 citations

, , +15

DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing

Kazutaka Nishina, Wenying Piao, Kie Yoshida‐Tanaka et al. · Nature Communications · 2015 · 126 citations · Full text

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol

Tomoko Nishina, Junna Numata, Kazutaka Nishina et al. · Molecular Therapy — Nucleic Acids · 2015 · 70 citations · Full text

Angubindin-1 opens the blood–brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system

Satoshi Zeniya, Hiroya Kuwahara, Kaiichi Daizo et al. · Journal of Controlled Release · 2018 · 57 citations · Full text

, , +19

Intrathecal AAV Serotype 9-mediated Delivery of shRNA Against TRPV1 Attenuates Thermal Hyperalgesia in a Mouse Model of Peripheral Nerve Injury

Takashi Hirai, Mitsuhiro Enomoto, Hidetoshi Kaburagi et al. · Molecular Therapy · 2013 · 55 citations · Full text

Rows per page

1–5 of 13